The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta
Over the past 20 years, orally administered biphosphonates have been used extensively in the management of a number of common skeletal disorders of different etiology. Recently, in clinical practice, in a number of cases in whom oral therapy is insufficient or contraindicated, intravenous adm...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2004-10-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/2828 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850042893032488960 |
|---|---|
| author | Pelin Adiyaman Gönül Ocal Merih Berberoğlu Olcay Evliyaoğlu Zehra Aycan Ergun Cetinkaya |
| author_facet | Pelin Adiyaman Gönül Ocal Merih Berberoğlu Olcay Evliyaoğlu Zehra Aycan Ergun Cetinkaya |
| author_sort | Pelin Adiyaman |
| collection | DOAJ |
| description |
Over the past 20 years, orally administered biphosphonates have been used extensively in the management of a number of common skeletal disorders of different etiology. Recently, in clinical practice, in a number of cases in whom oral therapy is insufficient or contraindicated, intravenous administration of pamidronate presents an alternative therapeutic option. In order to investigate the clinical and radiological effects of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta, a prospective open study of pamidronate treatment was undertaken in a cohort of eight bed-bounded (3.6-13.8 years) patients with severe osteoporosis and vertebral deformities. Pamidronate was administered at a dose of 0.5 mg/kg/ day for three days. Tri-monthly cyclic intravenous infusions were performed over-one year. Bone density, verebral corpus heights, estimated volumetric bone density and biochemical measurements were analyzed. Side effects of the therapy were determined via questionnaire. Significant reductions in the number of bone fractures and pain were observed in all patients. Ambulation scores were significantly altered and seven of eight patients became independent. Serum alkaline phosphatase levels decreased significantly. Lumbar X-ray and densitometry showed a striking improvement by the end of the treatment period. Even spaced dense lines corresponding to infusion periods were observed on roentgenograms of the radio-ulnar region. Pubertal progression and growth velocity were not affected inversely during therapy. Although we did not observe any severe side effect, one patient's blood urea nitrogen level was altered slightly. In conclusion, one year cyclical pamidronate treatment seems to be effective and safe in improving bone mineralization and in reducing fracture incidence in severe osteoporosis.
|
| format | Article |
| id | doaj-art-1c06099b76f34d13b4a9bed4f4b6aed1 |
| institution | DOAJ |
| issn | 0041-4301 2791-6421 |
| language | English |
| publishDate | 2004-10-01 |
| publisher | Hacettepe University Institute of Child Health |
| record_format | Article |
| series | The Turkish Journal of Pediatrics |
| spelling | doaj-art-1c06099b76f34d13b4a9bed4f4b6aed12025-08-20T02:55:24ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212004-10-01464The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfectaPelin Adiyaman0Gönül OcalMerih BerberoğluOlcay EvliyaoğluZehra AycanErgun CetinkayaDepartment of Pediatrics, Ankara University Faculty of Medicine, Ankara, Turkey. Over the past 20 years, orally administered biphosphonates have been used extensively in the management of a number of common skeletal disorders of different etiology. Recently, in clinical practice, in a number of cases in whom oral therapy is insufficient or contraindicated, intravenous administration of pamidronate presents an alternative therapeutic option. In order to investigate the clinical and radiological effects of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta, a prospective open study of pamidronate treatment was undertaken in a cohort of eight bed-bounded (3.6-13.8 years) patients with severe osteoporosis and vertebral deformities. Pamidronate was administered at a dose of 0.5 mg/kg/ day for three days. Tri-monthly cyclic intravenous infusions were performed over-one year. Bone density, verebral corpus heights, estimated volumetric bone density and biochemical measurements were analyzed. Side effects of the therapy were determined via questionnaire. Significant reductions in the number of bone fractures and pain were observed in all patients. Ambulation scores were significantly altered and seven of eight patients became independent. Serum alkaline phosphatase levels decreased significantly. Lumbar X-ray and densitometry showed a striking improvement by the end of the treatment period. Even spaced dense lines corresponding to infusion periods were observed on roentgenograms of the radio-ulnar region. Pubertal progression and growth velocity were not affected inversely during therapy. Although we did not observe any severe side effect, one patient's blood urea nitrogen level was altered slightly. In conclusion, one year cyclical pamidronate treatment seems to be effective and safe in improving bone mineralization and in reducing fracture incidence in severe osteoporosis. https://turkjpediatr.org/article/view/2828 |
| spellingShingle | Pelin Adiyaman Gönül Ocal Merih Berberoğlu Olcay Evliyaoğlu Zehra Aycan Ergun Cetinkaya The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta The Turkish Journal of Pediatrics |
| title | The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta |
| title_full | The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta |
| title_fullStr | The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta |
| title_full_unstemmed | The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta |
| title_short | The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta |
| title_sort | clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta |
| url | https://turkjpediatr.org/article/view/2828 |
| work_keys_str_mv | AT pelinadiyaman theclinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT gonulocal theclinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT merihberberoglu theclinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT olcayevliyaoglu theclinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT zehraaycan theclinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT erguncetinkaya theclinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT pelinadiyaman clinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT gonulocal clinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT merihberberoglu clinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT olcayevliyaoglu clinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT zehraaycan clinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta AT erguncetinkaya clinicalandradiologicalassessmentofcyclicintravenouspamidronateadministrationinchildrenwithosteogenesisimperfecta |